4//SEC Filing
Huntsman Ronald Kirk 4
Accession 0001493152-21-012901
CIK 0001716166other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 9:45 PM ET
Size
7.1 KB
Accession
0001493152-21-012901
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-05-25$5.38/sh+4,000$21,520→ 5,500 total
Holdings
- 333,334
Stock Option
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying) - 1,749,000(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.335 to $5.40.
- [F2]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F3]The option provides for vesting in five equal annual installments beginning on January 15, 2017.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 9:45 PM ET
- Size
- 7.1 KB